Grant awarded to Rivanna for developing sophisticated diagnostic ultrasound technology, worth $800,000.

The University of Virginia and Virginia Commonwealth University have formed an academic-industry partnership to develop the Accuro 3S diagnostic ultrasound system. This system, currently in the process of development and clinical validation, is intended for use in neuraxial anesthesia procedures.

Rivanna, the company behind the Accuro 3S, secured an $800,000 grant from the Virginia Catalyst Program to aid in its development. The Accuro 3S uses a dual-array ultrasound probe and the SpineNav-AI machine learning algorithm to facilitate continuous needle tracking and automate spinal landmark identification.

The research conducted by Dr. William Manson from the University of Virginia and Dr. David Evans from Virginia Commonwealth University will focus on the Accuro 3S's readiness for clinical use. The clinical and integration studies for Accuro 3S will be led by these two esteemed doctors.

The purpose of these studies is to assess the platform readiness of the Accuro 3S diagnostic ultrasound system for clinical adoption. No further details about the specific advanced product features being finalized and clinically validated were provided.

Virginia Catalyst will provide support for the finalization and clinical validation of these advanced product features. However, no information about the expected timeline for the development or release of the Accuro 3S diagnostic ultrasound system was provided.

The research partnership between the two universities and Rivanna will also focus on the Accuro 3S diagnostic ultrasound system. The system's research will include conducting studies on the Accuro 3S's effectiveness and safety during neuraxial anesthesia procedures.

Dr. David Evans, who works at the University of Virginia in Charlottesville, Virginia, will be a key contributor to this research. The Accuro 3S diagnostic ultrasound system is still in the process of development and clinical validation, and no information about the expected timeline for the completion of the clinical and integration studies was provided.

In conclusion, the partnership between the University of Virginia, Virginia Commonwealth University, and Rivanna marks an exciting step forward in the development of the Accuro 3S diagnostic ultrasound system. This system has the potential to revolutionize neuraxial anesthesia procedures by automating spinal landmark identification and facilitating continuous needle tracking.